Jean-Francois Martini
Sr Director, Translational strategy Guardant Health
Seminars
Tuesday 3rd February 2026
Transforming Therapeutic Frontiers: Expert Insights on Novel Epigenomic Biomarkers
6:00 pm
Discover how biopharma researchers and clinical oncologists are harnessing the power of novel epigenomic biomarkers to pinpoint the right patients most likely to benefit from your therapy refining your therapeutic strategies and ultimately bringing more effective medicine to the patients who need them.
Wednesday 4th February 2026
Revolutionizing Precision Oncology Through Cutting-Edge Epigenomic Biomarkers & AI-Enabled Data Solutions
10:00 am
- Integrate genomic and epigenomic insights to enhance understanding of tumor behavior
- Leverage ctDNA and epigenomic biomarkers for response prediction, cancer subtyping, and detection of treatment-emergent resistance
- Explore how Guardant Infinity and InfinityAI unite innovative testing with multimodal data solutions to deliver novel epigenomics biomarkers from research to clinic
